Cargando…

Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma

BACKGROUND: The goal of surveillance testing is to enable curative salvage therapy through early disease detection, however supporting evidence in gastroesophageal adenocarcinoma is limited. We evaluated frequency of successful salvage therapy and outcomes in patients who underwent surveillance. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Di M., Suzuki, Chihiro, Espin‐Garcia, Osvaldo, Lim, Charles H., Ma, Lucy X., Sun, Peiran, Sim, Hao‐Wen, Natori, Akina, Chan, Bryan A., Moignard, Stephanie, Chen, Eric X., Liu, Geoffrey, Swallow, Carol J., Darling, Gail E., Wong, Rebecca, Jang, Raymond W., Elimova, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196047/ https://www.ncbi.nlm.nih.gov/pubmed/32130793 http://dx.doi.org/10.1002/cam4.2948

Ejemplares similares

Comparison of Four Clinical Prognostic Scores in Patients with Advanced Gastric and Esophageal Cancer
por: Ma, Lucy X, et al.
Publicado: (2022)

Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma
por: Ma, Lucy X., et al.
Publicado: (2020)

Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma
por: Wang, Xin, et al.
Publicado: (2022)

Combination of clinical, radiomic, and “delta” radiomic features in survival prediction of metastatic gastroesophageal adenocarcinoma
por: Krishna, Satheesh, et al.
Publicado: (2023)

Esophageal abnormalities and the risk for gastroesophageal cancers—a histopathology-register-based study in Sweden
por: Ekheden, Isabella, et al.
Publicado: (2022)

Evaluation of gastroesophageal reflux disease and hiatal hernia as risk factors for lobectomy complications
por: Kaminski, Michael F., et al.
Publicado: (2022)

Risk factors and patterns of recurrence after curative resection in Gastroesophageal Junction Adenocarcinoma
por: Batool, Sadaf, et al.
Publicado: (2019)

Clinicopathological Determinants of an Elevated Systemic Inflammatory Response Following Elective Potentially Curative Resection for Colorectal Cancer
por: Watt, David G., et al.
Publicado: (2017)

Docetaxel, Cisplatin, and 5‐Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma
por: Fiteni, Frédéric, et al.
Publicado: (2016)

Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma
por: Gao, Xu-dong, et al.
Publicado: (2014)

Prognostic significance of postoperative pneumonia after curative resection for patients with gastric cancer
por: Tu, Ru‐Hong, et al.
Publicado: (2017)

FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape
por: Klempner, Samuel J., et al.
Publicado: (2019)

Anlotinib Combined with Toripalimab as Second-Line Therapy for Advanced, Relapsed Gastric or Gastroesophageal Junction Carcinoma
por: Jiang, Man, et al.
Publicado: (2022)

Targeted therapies for gastroesophageal cancers
por: Hsu, Andrew, et al.
Publicado: (2020)

Medical management of gastric cancer: a 2017 update
por: Charalampakis, Nikolaos, et al.
Publicado: (2017)

Anticancer drugs approved by the Food and Drug Administration for gastrointestinal malignancies: Clinical benefit and price considerations
por: Jiang, Di Maria, et al.
Publicado: (2019)

Positioning of second‐line treatment for advanced gastric and gastroesophageal junction adenocarcinoma
por: Pericay, Carles, et al.
Publicado: (2016)

Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction
por: Bornschein, Jan, et al.
Publicado: (2019)

Multi‐institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2019)

Eurolung risk score is associated with long-term survival after curative resection for lung cancer
por: Brunelli, Alessandro, et al.
Publicado: (2021)

Patterns of recurrence after curative D2 resection for gastric cancer: Implications for postoperative radiotherapy
por: Xu, Jing, et al.
Publicado: (2020)

Development and validation of a nomogram to predict survival after curative resection of nonmetastatic colorectal cancer
por: Hong, Tingting, et al.
Publicado: (2020)

A piece of the ‘chemobrain’ puzzle: pNF-H
por: Natori, Akina, et al.
Publicado: (2015)

Initial Report of Second‐Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi‐Institutional Retrospective Analysis
por: Klempner, Samuel J., et al.
Publicado: (2018)

Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status
por: Wood, Anthony C, et al.
Publicado: (2022)

Editorial for the series on gastric and gastroesophageal cancer treatment in 2020
por: Almhanna, Khaldoun
Publicado: (2020)

Cost-effectiveness of surveillance with CT colonography after resection of colorectal cancer
por: Kuntz, Karen M, et al.
Publicado: (2020)

Expression and prognostic role of STAT5a across cancer types
por: Maninang, Christine, et al.
Publicado: (2023)

Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2‐Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
por: Al‐Batran, Salah‐Eddin, et al.
Publicado: (2020)

Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
por: Catenacci, Daniel V., et al.
Publicado: (2021)

International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma
por: Ben Aim, Laurene, et al.
Publicado: (2022)

Clinical Relevance of Gastroesophageal Cancer Associated SNPs for Oncologic Outcome After Curative Surgery
por: Jung, Jin-On, et al.
Publicado: (2021)

Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population‐based study
por: Zhang, Panpan, et al.
Publicado: (2018)

The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients
por: Hsieh, Mei‐Chin, et al.
Publicado: (2016)

Low expression of WW domain‐containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2018)

Clinical predictive factors of long‐term survival after curative resection of pancreatic cancer: a retrospective study
por: Nakano, Yutaka, et al.
Publicado: (2017)

Survival times are similar among patients with peritoneal, hematogenous, and nodal recurrences after curative resections for gastric cancer
por: Sawaki, Koichi, et al.
Publicado: (2020)

Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)
por: Kemeny, M. Margaret, et al.
Publicado: (2022)

Conditional survival in patients with esophageal or gastroesophageal junction cancer after receiving various treatment modalities
por: Deng, Wei, et al.
Publicado: (2020)

Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer
por: Harada, Hiroaki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8iu0fdc6d6qhsrtdv0e7rvd76p